Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-27T21:20:42.327Z Has data issue: false hasContentIssue false

Improvement of paranoid schizophrenia coincides with reduction of testosterone substitution of hypogonadotropic hypogonadism

Published online by Cambridge University Press:  16 April 2020

J Deckert
Affiliation:
Department of Psychiatry, University of Würzburg, Füchsleinstr 15, 87 Würzburg, Germany
HC Estler
Affiliation:
Department of Psychiatry, University of Würzburg, Füchsleinstr 15, 87 Würzburg, Germany
KP Lesch
Affiliation:
Department of Psychiatry, University of Würzburg, Füchsleinstr 15, 87 Würzburg, Germany

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Copyright
Copyright © Elsevier, Paris 1993

References

Häfner, HRiecher-Rössler, AMaurer, KFätkenheuer, BLöffier, W (1992) First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Psychiatry Clin Neurosci 242, 109118CrossRefGoogle ScholarPubMed
Propping, PFriedl, W (1988) Genetic studies of biochemical, pathophysiological and pharmacological factors in schizophrenia. In: Handbook of Schizophrenia, vol 3 (Tsuang, MTSimpson, JC eds). Elsevier, Amsterdam, 579608Google Scholar
Williamson, DJYoung, AH (1992) Psychiatric effects of androgenic and anabolic androgenic steroid abuse in men: a brief review of the literature. J Psychopharmacol 6, 2026CrossRefGoogle ScholarPubMed
Wilson, JDGriffin, JE (1987) Disorders of sexual disorientation. In: Harrison's Principles of Internal Medicine (Braunwald, EIsselbacher, KJPetersdorf, RGWilson, JDMartin, JBFauci, AS eds). McGraw-Hill, New York, 18401853Google Scholar
Submit a response

Comments

No Comments have been published for this article.